Evidence map›Paper›PMID 31312309›Full record

ArticleThe Pan African medical journal2019

Angiotensin-converting enzyme insertion/deletion gene polymorphisms and the risk of glioma in an Algerian population.

Ikram Hana Benenemissi, Karima Sifi, Lakhder Khalil Sahli, Ouarda Semmam, Noureddine Abadi, Dalila Satta

Abstract read
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ikram Hana BenenemissiDepartment of Animal Biology, Faculty of Life and Natural Sciences, Molecular and Cellular Biology Laboratory, University of Constantine 1, Constantine, Algeria.
Karima SifiDepartment of Biochemistry, Ben Badis University Hospital, Biology and Genetics Research Laboratory, Faculty of Medicine, University of Constantine 3, Constantine, Algeria.
Lakhder Khalil SahliDepartment of Neurosurgery, Regional Military Hospital of Constantine (HMRUC), Constantine, Algeria.
Ouarda SemmamDepartment of Animal Biology, Faculty of Life and Natural Sciences, Molecular and Cellular Biology Laboratory, University of Constantine 1, Constantine, Algeria.
Noureddine AbadiDepartment of Biochemistry, Ben Badis University Hospital, Biology and Genetics Research Laboratory, Faculty of Medicine, University of Constantine 3, Constantine, Algeria.
Dalila SattaDepartment of Animal Biology, Faculty of Life and Natural Sciences, Molecular and Cellular Biology Laboratory, University of Constantine 1, Constantine, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionJust recently, it has been established that the angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism is linked to the pathogenesis and to the evolution of human cancers. Therefore, the present study was concerned with the investigation of an eventual association between glioma and I/D polymorphism of the ACE gene.

methodsThe expression of ACE gene was detected by polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) analysis in 36 Algerian patients with glioma and 195 healthy controls.

resultsIn glioma cases, allelic frequencies and genotypes distribution of the ACE I/D polymorphism were different from controls cases. ACE DD genotype were highly presented in glioma cases (63.9%) than controls (33.8%) and conferred 3.64-fold risk for predisposition in glioma cases (vs ID genotype, p<0.001). Recessive model (ACE II + ID genotypes vs DD) was associated with a 72% reduced risk of glioma (OR = 0.28, 95% CI: 0.13-0.60, p <0.001). Per copy D allele frequency was found higher in glioma cases (79.2%) than in controls (63.3 %), OR = 2.20, 95% CI: 1.20 - 4.03, p = 0.009.

conclusionThe obtained data showed that the presence of the D allele might be a risk factor for the development of glioma. Further studies considering different ethnic groups with large samples are required to confirm this finding.

Indexed as

Genetic Predisposition to DiseaseAdultAlgeriaBrain NeoplasmsCase-Control StudiesFemaleGene DeletionGene FrequencyGenotypeGliomaHumansMaleMiddle AgedMutagenesis, InsertionalPeptidyl-Dipeptidase APolymerase Chain ReactionACE protein, humanPeptidyl-Dipeptidase AAngiotensin-converting enzymegene polymorphismGliomainsertion/deletion

Identifiers

PMID31312309
PMCPMC6620085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.